IN8bio Inc (INAB) Stock Price

1.20 ▲ +0.01 (+0.84%)
Open: 1.215 Vol: 29.74K Day's range: 1.20 - 1.2422 Jul 24, 16:00 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
INAB Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 1.31▼ 1.31▼ 1.31▼ 1.22▼ 1.33▼
MA10 1.34▼ 1.34▼ 1.33▼ 1.30▼ 1.45▼
MA20 1.36▼ 1.36▼ 1.36▼ 1.35▼ 1.51▼
MA50 1.40▼ 1.41▼ 1.41▼ 1.46▼ 1.81▼
MA100 1.41▼ 1.42▼ 1.43▼ 1.53▼ 1.25▼
MA200 1.44▼ 1.53▼ 1.53▼ 1.73▼ 1.34▼
  5 mins 30 mins Hourly Daily Weekly
MACD -0.015▼ -0.016▼ -0.016▼ -0.016▼ -0.024▼
RSI 32.216▼ 32.857▼ 33.108▼ 33.187▼ 39.677▼
STOCH 36.111     35.185     35.185     9.330▼ 10.412▼
WILL %R -100.000▼ -100.000▼ -100.000▼ -96.329▼ -98.551▼
CCI -185.878▼ -198.064▼ -195.718▼ -110.831▼ -154.597▼
Latest Filters Detected On INAB
▲ GAP $INAB Open Gap Up %2 Set Alert
IN8bio Inc News
IN8bio Announces Publication in The Journal of Clinical Oncology Demonstrating DeltEx™ DRI Doubles Progression-Free Survival in Newly Diagnosed Glioblastoma
Thursday, July 09, 2026 05:00 AM
First peer-reviewed publication of chemotherapy-resistant gamma-delta T cells (DeltEx Drug Resistant Immunotherapy or DRI) clinical results in newly diagnosed glioblastoma Repeat-dose patients ...
IN8bio Announces Publication in Nature Communications Highlighting Advances in Gamma-Delta T Cell Engineering and Combination Therapies
Wednesday, June 03, 2026 05:29 AM
NEW YORK, June 03, 2026 (GLOBE NEWSWIRE) -- IN8bio, Inc. (NASDAQ: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta (γδ) T cell therapies and T cell engagers (TCEs) ...
IN8bio to Showcase Next-Generation T Cell Engager Platform and New Clinical Data at Upcoming R&D Day and Medical Conferences
Wednesday, May 06, 2026 05:00 AM
Featuring presentations on our T cell engager (TCE) platform for autoimmune diseases and our clinical program in GBM, with a clinical perspective from renowned neuro-oncologist Dr. David Reardon, ...
INAB historical stock data
date open high low close volume
24/07/26 1.215 1.2422 1.20 1.20 29,742
23/07/26 1.22 1.22 1.19 1.19 29,190
22/07/26 1.2496 1.2496 1.225 1.23 21,452
21/07/26 1.2205 1.25 1.2205 1.24 34,697
20/07/26 1.32 1.33 1.23 1.26 50,599
17/07/26 1.35 1.37 1.32 1.33 63,501
16/07/26 1.44 1.4624 1.38 1.38 104,984
15/07/26 1.389 1.46 1.389 1.44 75,236
14/07/26 1.37 1.38 1.35 1.38 16,249
13/07/26 1.32 1.38 1.32 1.34 75,092
Quote Details
52wk Low:1.17
52wk High:2.73
Vol:29.74K
Avg Vol(3m):1M
1Y Chng:-47.14%
1M Chng:-16.67%
Add to Watch List
More Information
Index US Composite
Market Cap. 11.41M